CASABIANCA, ANNA
 Distribuzione geografica
Continente #
NA - Nord America 11.205
EU - Europa 6.062
AS - Asia 3.680
SA - Sud America 365
Continente sconosciuto - Info sul continente non disponibili 260
AF - Africa 67
OC - Oceania 21
Totale 21.660
Nazione #
US - Stati Uniti d'America 11.054
GB - Regno Unito 2.289
CN - Cina 1.807
SG - Singapore 1.035
IT - Italia 839
UA - Ucraina 775
RU - Federazione Russa 478
SE - Svezia 422
FI - Finlandia 338
TR - Turchia 303
DE - Germania 294
BR - Brasile 274
FR - Francia 259
IE - Irlanda 180
VN - Vietnam 169
JP - Giappone 98
CA - Canada 92
IN - India 60
PL - Polonia 41
BD - Bangladesh 40
BE - Belgio 35
AR - Argentina 27
MA - Marocco 27
HK - Hong Kong 26
MX - Messico 25
NL - Olanda 24
KR - Corea 21
ZA - Sudafrica 20
AU - Australia 18
ES - Italia 18
EC - Ecuador 17
IQ - Iraq 16
CL - Cile 14
DK - Danimarca 13
SA - Arabia Saudita 13
IR - Iran 12
UZ - Uzbekistan 12
CO - Colombia 10
EU - Europa 10
PY - Paraguay 10
LT - Lituania 9
AE - Emirati Arabi Uniti 8
MY - Malesia 8
CR - Costa Rica 7
EE - Estonia 7
ID - Indonesia 7
JO - Giordania 7
KZ - Kazakistan 7
CH - Svizzera 6
AT - Austria 5
PA - Panama 5
PK - Pakistan 5
PT - Portogallo 5
VE - Venezuela 5
EG - Egitto 4
JM - Giamaica 4
MD - Moldavia 4
PH - Filippine 4
TG - Togo 4
AZ - Azerbaigian 3
BG - Bulgaria 3
DZ - Algeria 3
GR - Grecia 3
GT - Guatemala 3
HN - Honduras 3
IL - Israele 3
LA - Repubblica Popolare Democratica del Laos 3
LV - Lettonia 3
NO - Norvegia 3
NP - Nepal 3
NZ - Nuova Zelanda 3
OM - Oman 3
PE - Perù 3
PR - Porto Rico 3
TT - Trinidad e Tobago 3
AL - Albania 2
AM - Armenia 2
BB - Barbados 2
BO - Bolivia 2
CI - Costa d'Avorio 2
ET - Etiopia 2
HR - Croazia 2
KE - Kenya 2
NI - Nicaragua 2
RO - Romania 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
CG - Congo 1
CM - Camerun 1
CW - ???statistics.table.value.countryCode.CW??? 1
CZ - Repubblica Ceca 1
GD - Grenada 1
GY - Guiana 1
HU - Ungheria 1
KG - Kirghizistan 1
KH - Cambogia 1
LK - Sri Lanka 1
NG - Nigeria 1
QA - Qatar 1
Totale 21.410
Città #
Southend 2.100
Fairfield 1.143
Ashburn 1.122
Woodbridge 1.010
Ann Arbor 901
Houston 884
Jacksonville 624
Chandler 495
Seattle 466
San Jose 455
Singapore 453
Cambridge 441
Dallas 426
Wilmington 390
Nanjing 336
Beijing 265
Urbino 224
Izmir 223
Boardman 184
Dublin 170
New York 170
Helsinki 153
Council Bluffs 143
Nanchang 138
Los Angeles 128
Moscow 109
Lauterbourg 97
Princeton 97
San Mateo 97
Tianjin 84
Shenyang 75
Santa Clara 71
Düsseldorf 68
Ho Chi Minh City 60
Istanbul 59
Changsha 58
Hebei 57
Jiaxing 43
Munich 42
Bremen 41
Buffalo 41
London 39
Chicago 37
San Diego 37
Kunming 35
Orem 35
Toronto 35
Hanoi 33
São Paulo 32
Brussels 30
San Francisco 30
Shanghai 30
Frankfurt am Main 29
Jinan 28
Velikiy Novgorod 28
Hangzhou 26
Rome 26
The Dalles 26
Hong Kong 25
Milan 25
Tokyo 25
Warsaw 22
Atlanta 21
Casablanca 21
Denver 21
Brooklyn 19
Guangzhou 19
Turku 19
Montreal 18
Seongnam 18
Zhengzhou 17
Cagli 16
Johannesburg 15
Stockholm 15
Lanzhou 14
Amsterdam 13
Chennai 13
Napoli 13
North Bergen 13
Phoenix 13
Taizhou 13
Boston 12
Des Moines 12
Leawood 12
Manchester 12
Mülheim 12
Carpi 11
Changchun 11
Kraków 11
Mumbai 11
Ningbo 11
Rio de Janeiro 11
Auburn Hills 10
Charlotte 10
Fano 10
Poplar 10
Rimini 10
Tashkent 10
Augusta 9
Falls Church 9
Totale 15.291
Nome #
Switching to elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate single-tablet regimen (Stribild†): effects on T-cell compartment and HIV reservoirs 542
Glutathione Depletion Is Linked with Th2 Polarization in Mice with a Retrovirus-Induced Immunodeficiency Syndrome, Murine AIDS: Role of Proglutathione Molecules as Immunotherapeutics 443
Effect of starvation on survival and virulence expression of Aeromonas hydrophila from different sources 361
Antiviral and Immunomodulatory Properties of New Pro-Glutathione (GSH) Molecules. 322
A Real Time PCR Platform for the Simultaneous Quantification of Total and Extrachromosomal HIV DNA Forms in Blood of HIV-1 Infected Patients 303
A recombinant human 'mini'-hexokinase is catalytically active and regulated by hexose 6-phosphates 300
A new one-step RT-PCR method for virus quantitation in murine AIDS. 291
Inhibition of murine AIDS by pro-glutathione (GSH) molecules 289
2\',3\'-Dideoxycytidine cytotoxicity in human macrophages. 285
2',3'-Dideoxycytidine induced drug resistance in human cells 283
Erythrocytes as carriers of antisense PNA addressed against HIV-1 gag-pol transframe domain 277
Molecules Altering the Intracellular Thiol Content Modulate NF-kB and STAT-1/IRF-1 Signalling Pathways and IL-12 p40 and IL-27 p28 Production in Murine Macrophages 277
2',3'-Dideoxycytidine metabolism in a new drug-resistant cell line 277
Effect of macrophage depletion on viral DNA rebound following antiretroviral therapy in a murine model of AIDS (MAIDS) 272
New Approach using the real-time PCR method for estimation of the toxic marine dinoflagellate Ostreopsis cf. ovata in marine environment 269
HIV-1 Tat immunization restores immune homeostasis and attacks the HAART-resistant blood HIV DNA: results of a randomized phase II exploratory clinical trial 269
Development of a real time PCR assay using SYBR Green I for provirus load quantification in a murine model of AIDS 267
Pharmacokinetic and antiretroviral activity in mice of oral [P(1),P(2)-bis[2-(adenin-9-yl)ethoxymethyl]phosphonate], a prodrug of 9-(2-phosphonylmethoxyethyl)adenine 266
Fast and sensitive quantitative detection of HIV DNA in whole blood leucocytes by SYBR Green I real-time PCR assay 259
2',3'-Dideoxycytidine induced drug-resistance in human cells 258
Control of the HIV-1 DNA Reservoir Is Associated In Vivo and In Vitro with NKp46/NKp30 (CD335 CD337) Inducibility and Interferon Gamma Production by Transcriptionally Unique NK Cells 252
Pharmaceutical composition or composition package containing a pyrimidine nucleoside analog and a purine nucleoside analog 249
Fast and sensitive quantitative detection of HIV DNA in whole blood leucocytes by SYBR green I real-time PCR assay. 248
Targeting antiviral nucleotide analogues to macrophages 246
Development of a real-time PCR assay using SYBR Green I for provirus load quantification in a murine model of AIDS 245
Inhibition of murine AIDS by combination of AZT and dideoxycytidine 5'-triphosphate 236
Macrophage protection by addition of glutathione (GSH)-loaded erythrocytes to AZT and DDI in a murine AIDS model. 236
Mitochondria as cellular hub in neonatal hypoxic-ischemic encephalopathy: identification of melatonin-responsive biomarkers predicting brain damage severity 234
Comparative analysis of T-cell turnover and homeostatic parameters in HIV-infected patients with discordant immune-virological responses to HAART 234
Antiretroviral effect of combined zidovudine and reduced glutathione therapy in murine AIDS. 233
Genetic diversity of the genus Ostreopsis Schmidt:phylogeographical considerations and molecularmethodology applications for field detectionin the Mediterranean Sea 229
Inhibition of murine AIDS by a heterodinucleotide of azidothymidine and 9-(R)-2-(phosphonomethoxypropyl)adenine 227
Protein degradation and apoptotic death in lymphocytes during fiv infection: activation of the ubiquitin-proteasome proteolytic system , (1999) 381-390 226
Inhibition of murine AIDS by reduced glutathione. 225
Erythrocytes as carriers of antisense PNA adressed againist HIV-1 gag-pol transframe domain 224
Quantification of the Toxic Dinoflagellate Ostreopsis spp. by qPCR Assay in Marine Aerosol 223
Monitoring toxic Ostreopsis cf. ovata in recreational waters using a qPCR assay. 222
Human hexokinase type I microheterogeneity is due to different amino-terminal sequences 220
Red blood cells as advanced drug delivery systems for antiviral nucleoside analogues 220
New treatment protocol including lympholytic and antiretroviral drugs to inhibit murine AIDS 219
Repeated cycles of alternate administration of fludarabine and zidovudine plus didanosine inhibits murine AIDS and reduces proviral DNA content in lymph nodes to undetectable levels 218
HIV-infected long-term nonprogressors display a unique correlative pattern between the interleukin-7/interleukin-7 receptor circuit and T-cell homeostasis 218
Efficient inhibition by Raltegravir of HIV-1 Infection in Human Primary Macrophages and in CD4+T Lymphocytes and of the cellular Apoptosis HIV-1 correlated 217
A comparative analysis of unintegrated HIV-1 DNA measurement as a potential biomarker of the cellular reservoir in the blood of patients controlling and non-controlling viral replication 217
Increased Bone Marrow Interleukin-7 (IL-7)/IL-7R Levels but Reduced IL-7 Responsiveness in HIV-Positive Patients Lacking CD4+ Gain on Antiviral Therapy 215
Different kinetics of viral replication and DNA integration in the main HIV-1 cellular reservoirs in the presence and absence of integrase inhibitors 215
Continued Decay of HIV Proviral DNA Upon Vaccination With HIV-1 Tat of Subjects on Long-Term ART: An 8-Year Follow-Up Study 214
Targeting nucleotide dimers containing antiviral nucleosides 213
HIV-Tat immunization induces cross-clade neutralizing antibodies and CD4(+) T cell increases in antiretroviral-treated South African volunteers: a randomized phase II clinical trial 210
Macrophage protection by nucleoside and nucleotide analogue administration 197
Molecular studies in Duchenne and Becker muscular dystrophies 196
Immunophenotype and Function of CD38-Expressing CD4+ and CD8+ T Cells in HIVInfected Patients Undergoing Suppressive Combination Antiretroviral Therapy 196
Protein degradation and apoptotic death in lymphocytes during FIV infection: activation of the ubiquitin-proteasome proteolytic system 195
Human hexokinase type I microheterogeneity is due to different amino-terminal 194
Effect of macrophage depletion on viral DNA rebound following antiretroviral therapy in a murine model of AIDS 193
Up-regulation of the ubiquitin-conjugating and proteolytic systems in murine acquired immunodeficiency syndrome 192
Comparing Heterologous and Homologous {COVID}-19 Vaccination: A Longitudinal Study of Antibody Decay 192
The soluble but not mitochondrially bound hexokinase is a substrate for the ATP- and ubiquitin-dependent proteolytic system 191
Inhibition of murine AIDS by combination of AZT and DDCTP-loaded erythrocytes 190
T-Cell Dynamics and Homeostatic Pathways in HAART-Treated HIV-Infected Patients. 188
Inhibition of Murine AIDS by a New Azidothymidine Homodinucleotide. 187
Competitive PCR for quntification of BM5d proviral DNA in mice with AIDS. 186
A p12 gag gene homologue is present in the mouse genome. 185
Inhibition of murine AIDS by a new azidothymidine homodinucleotide 184
Synthesis and targeted delivery of an azidothymidine homodinucleotide conferring protection to macrophages against retroviral infection 183
GSH and analogs in antiviral therapy 182
Erythrocyte-based targeted release to macrophages of an azidothymidine homodinucleotide prevents retroviral infection 181
Efficacy and toxicity of long-term administration of 2',3'-dideoxycytidine in the LP-BM5 murine-induced immunodeficiency model 180
Liposomes as carriers of the antiretroviral agent dideoxycytidine-5'-triphosphate. 180
HIV-infected long-term nonprogressors display a unique correlative pattern between the interleukin-7/interleukin-7 receptor circuit and T-cell homeostasis. 179
Inhibition of murine retrovirus induced immunodeficiency by nucleoside analogues and combination therapy. 179
Metabolism, mitochondrial uptake and toxicity of 2’,3’-dideoxycytidine 178
Drug-loaded red blood cell-mediated clearance of HIV-1 macrophage reservoir by selective inhibition of STAT1 expression. 178
Inhibition of HIV-1 and LP-BM5 replication in macrophages by dideoxycytidine and dideoxycytidine 5'-triphosphate 177
Inhibition of murine AIDS by alternate administration of azidothimidine and fludarabine monofosfate. 177
Evaluation of Two-Month Antibody Levels after Heterologous ChAdOx1-S/BNT162b2 Vaccination Compared to Homologous ChAdOx1-S or BNT162b2 Vaccination 175
BIOTECNOLOGIE: APPLICAZIONI NEL SETTORE MEDICO E FARMACEUTICO 170
Macrophage protection by nucleoside and nucleotide analogue administration 169
Erythrocytes as carriers of reduced glutathione (GSH) in the treatment of retroviral infections 169
Targeting antiviral nucleotide analogues to macrophages 167
Role of macrophage protection in the development of murine AIDS. 164
Macrophage depletion by Clodronate-loaded erythrocytes 162
Red blood cells as carriers of drugs against retroviruses 162
Molecular basis of the 2',3'-dideoxycytidine induced drug-resistance in human cells 161
Melatonin Reduces Mito-Inflammation in Ischaemic Hippocampal HT22 Cells and Modulates the cGAS–STING Cytosolic DNA Sensing Pathway and FGF21 Release 158
Hexokinase is not ubiquitaned when mitochondrial-bound 157
Reduction of Immune Activation and Partial Recovery of Staphylococcal Enterotoxin B-Induced Cytokine Production After Switching to an Integrase Strand Transfer Inhibitor-Containing Regimen: Results from an Observational Cohort Study 156
Inhibition of murine retrovirus induced immunodeficiency by nucleoside analogues and combination therapy. 155
New drug combinations for the treatment of murine AIDS and macrophage protection. 154
Analysis of humoral and cellular immune activation up to 21 months after heterologous and homologous COVID-19 vaccination 151
Studio delle dinamiche di crescita di Ostreopsis cf. ovata con nuove metodologie molecolari di qrt-PCR 149
Role of macrophage protection in the development of murine AIDS 145
The inhibitory effect of ddC on HIV replication diminishes in cells that are chronically exposed to the drug 140
Persistence of Unintegrated HIV DNA Associates With Ongoing NK Cell Activation and CD34+DNAM-1brightCXCR4+ Precursor Turnover in Vertically Infected Patients Despite Successful Antiretroviral Treatment 133
Rapid monitoring of SARS-CoV-2 variants of concern through high-resolution melt analysis 124
External quality assessment of HIV-1 DNA quantification assays used in the clinical setting in Italy 119
Red blood cells as carriers of antiviral agents 118
Primary HIV infection features colonic damage and neutrophil inflammation yet containment of microbial translocation 114
Red blood cells as carriers af antiviral agents 111
SARS-CoV-2 RNA Detection on Environmental Surfaces in a University Setting of Central Italy 105
Totale 21.223
Categoria #
all - tutte 74.886
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.886


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022869 0 0 0 132 31 59 46 62 108 87 67 277
2022/20231.571 195 67 19 192 164 338 7 103 294 62 76 54
2023/2024496 43 35 38 42 34 158 14 34 2 46 3 47
2024/20251.682 90 55 337 109 60 111 219 87 191 119 192 112
2025/20264.306 384 388 619 723 373 278 425 126 341 292 270 87
2026/2027868 126 86 346 310 0 0 0 0 0 0 0 0
Totale 21.660